Merck is investing $250 million in a Swiss biotechnology facility

Merck is investing $250 million in a Swiss biotechnology facility

In Corsier-sur-Vevey, Switzerland the Merck Biotech Center for Biotech Development and manufacturing in clinical studies announced an investment of US$ 250 million in a new facility. Driven by the growth of the R+D pipeline for healthcare business, this investment will…